Career Enhancement Program (CEP)

职业提升计划(CEP)

基本信息

  • 批准号:
    10227735
  • 负责人:
  • 金额:
    $ 9.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-30 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

CAREER ENHANCEMENT PROGRAM SUMMARY The overall Specific Aim of the Career Enhancement Program (CEP) is to 1) recruit and develop the careers of junior faculty who are committed to translational research in prostate cancer (PCa), and to 2) identify mid- and senior-level investigators who are already established in another area of research, but want to redirect their focus to the field of PCa. Building on the already existing outstanding programs and excellent resources for translational and clinical research in PCa at Weill Cornell Medicine (WCM) and the Columbia University Medical Center, our CEP is designed to develop future leaders in PCa research. Using a rigorous grant selection process, our CEP Advisory Committee (AC), will identify candidates with the highest potential for success and who are committed to careers in PCa research. The AC members will make recommendations to the WCM SPORE's Executive Committee for funding and then closely monitor the progress of all awarded investigators to ensure that the Program's goals in research, education, and scientific and grant writing are met. They will also provide positive research role models in a supportive academic environment. The ultimate goal of the CEP is to provide awardees with the knowledge and tools necessary for successful clinical, translational, and/or basic science PCa research careers. At the conclusion of their involvement with the CEP, awardees will be able to design and conduct hypothesis-driven PCa research, with significantly increased abilities to obtain peer-reviewed grant funding from federal or other extramural sources. Drs. Douglas Scherr and Lorraine Gudas, each of who have extensive experience in mentoring and developing the career of junior faculty, will oversee the CEP. As part of the CEP, we will also educate and mentor physicians and laboratory-based scientists in cross collaborations that will lead to the design and conduct of hypothesis-driven clinical/translational therapeutic research in PCa by creating a collaborative and productive research setting within the PCa SPORE.
职业发展计划摘要 职业提升计划(CEP)的总体具体目标是:1)招募和发展 致力于前列腺癌(PCa)转化研究的初级教师的职业生涯,以及2) 确定已经在另一个研究领域建立的中级和高级研究人员,但 想把他们的注意力转移到PCa领域。在现有优秀项目的基础上, 威尔康奈尔医学(WCM)PCa转化和临床研究的优秀资源, 在哥伦比亚大学医学中心,我们的CEP旨在培养PCa研究的未来领导者。 使用严格的赠款选择过程,我们的CEP咨询委员会(AC)将确定候选人, 成功的最高潜力,并致力于PCa研究事业。AC成员 将向WCM SPORE执行委员会提出资金建议,然后密切 监督所有获奖研究人员的进展,以确保该计划的研究目标, 教育、科学和拨款写作都得到了满足。他们还将提供积极的研究榜样, 支持性的学术环境。CEP的最终目标是为获奖者提供 成功进行临床、转化和/或基础科学PCa研究所需的知识和工具 careers.在他们参与CEP的结论,获奖者将能够设计和进行 假设驱动PCa研究,获得同行评审资助的能力显著提高 来自联邦或其他校外来源的资金。 Drs.道格拉斯谢尔和洛林古达斯,他们每个人都有丰富的经验,指导和 发展初级教师的职业生涯,将监督CEP。作为CEP的一部分,我们还将教育和 指导医生和实验室的科学家在交叉合作,这将导致设计和 通过建立一个合作的、以假设为导向的临床/转化治疗研究, 在PCa SPORE内进行生产性研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LORRAINE J GUDAS其他文献

LORRAINE J GUDAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LORRAINE J GUDAS', 18)}}的其他基金

CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention
CD 1530,一种 RAR γ 激动剂,用于预防口腔鳞状细胞癌
  • 批准号:
    10583911
  • 财政年份:
    2023
  • 资助金额:
    $ 9.77万
  • 项目类别:
Gene Nutrient Interactions in Kidney Function
肾功能中的基因营养相互作用
  • 批准号:
    10816057
  • 财政年份:
    2023
  • 资助金额:
    $ 9.77万
  • 项目类别:
Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases
揭示视黄酸受体β在酒精性肝病中的作用
  • 批准号:
    10019450
  • 财政年份:
    2019
  • 资助金额:
    $ 9.77万
  • 项目类别:
Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases
揭示视黄酸受体β在酒精性肝病中的作用
  • 批准号:
    9896234
  • 财政年份:
    2019
  • 资助金额:
    $ 9.77万
  • 项目类别:
Gene Nutrient Interactions in Kidney Function
肾功能中的基因营养相互作用
  • 批准号:
    10444744
  • 财政年份:
    2017
  • 资助金额:
    $ 9.77万
  • 项目类别:
Gene Nutrient Interactions in Kidney Function
肾功能中的基因营养相互作用
  • 批准号:
    10066343
  • 财政年份:
    2017
  • 资助金额:
    $ 9.77万
  • 项目类别:
Gene Nutrient Interactions in Kidney Function
肾功能中的基因营养相互作用
  • 批准号:
    10676812
  • 财政年份:
    2017
  • 资助金额:
    $ 9.77万
  • 项目类别:
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers
(PQ1) 头颈癌和食管癌小鼠模型癌前区域的表征
  • 批准号:
    9303314
  • 财政年份:
    2016
  • 资助金额:
    $ 9.77万
  • 项目类别:
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers
(PQ1) 头颈癌和食管癌小鼠模型癌前区域的表征
  • 批准号:
    9903826
  • 财政年份:
    2016
  • 资助金额:
    $ 9.77万
  • 项目类别:
(PQ1) Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal Cancers
(PQ1) 头颈癌和食管癌小鼠模型癌前区域的表征
  • 批准号:
    9098367
  • 财政年份:
    2016
  • 资助金额:
    $ 9.77万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 9.77万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.77万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 9.77万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.77万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 9.77万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.77万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 9.77万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 9.77万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 9.77万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.77万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了